Copyright © 2008 Panagiotis Skendros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. G. Pappas, N. Akritidis, M. Bosilkovski, and E. Tsianos, “Brucellosis,” The New England Journal of Medicine, vol. 352, no. 22, pp. 2325–2336, 2005. View at Publisher · View at Google Scholar · View at PubMed
2. G. Pappas, P. Papadimitriou, N. Akritidis, L. Christou, and E. V. Tsianos, “The new global map of human brucellosis,” The Lancet Infectious Diseases, vol. 6, no. 2, pp. 91–99, 2006. View at Publisher · View at Google Scholar · View at PubMed
3. P. Yagupsky and E. J. Baron, “Laboratory exposures to brucellae and implications for bioterrorism,” Emerging Infectious Diseases, vol. 11, no. 8, pp. 1180–1185, 2005.
4. Z. A. Memish and H. H. Balkhy, “Brucellosis and international travel,” Journal of Travel Medicine, vol. 11, no. 1, pp. 49–55, 2004.
5. S. Al Dahouk, H. Neubauer, A. Hensel, et al., “Changing epidemiology of human brucellosis, Germany, 1962–2005,” Emerging Infectious Diseases, vol. 13, no. 12, pp. 1895–1900, 2007.
6. E. Gotuzzo and C. Carrillo, “Brucella,” in Infectious Diseases, S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow, Eds., pp. 1837–1845, W.B. Saunders, Philadelphia, Pa, USA, 2nd edition, 1998.
7. E. F. Berbari and W. R. Wilson, “Brucella, Francisella, Pasteurella, Yersinia and HACEK,” in Current Diagnosis & Treatment in Infectious Diseases, W. R. Wilson and M. A. Sande, Eds., pp. 630–631, McGraw-Hill, New York, NY, USA, 2001.
8. J. de Bagues Maria-Pilar, S. Dudal, J. Dornand, and A. Gross, “Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation,” Clinical Immunology, vol. 114, no. 3, pp. 227–238, 2005. View at Publisher · View at Google Scholar · View at PubMed
9. U. E. Schaible, H. L. Collins, and S. H. E. Kaufmann, “Confrontation between intracellular bacteria and the immune system,” Advances in Immunology, vol. 71, pp. 267–377, 1999. View at Publisher · View at Google Scholar
10. B. Golding, D. E. Scott, O. Scharf, et al., “Immunity and protection against Brucella abortus,” Microbes and Infection, vol. 3, no. 1, pp. 43–48, 2001. View at Publisher · View at Google Scholar
11. S. Yingst and D. L. Hoover, “T cell immunity to brucellosis,” Critical Reviews in Microbiology, vol. 29, no. 4, pp. 313–331, 2003. View at Publisher · View at Google Scholar
12. E. Billard, C. Cazevieille, J. Dornand, and A. Gross, “High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis,” Infection and Immunity, vol. 73, no. 12, pp. 8418–8424, 2005. View at Publisher · View at Google Scholar · View at PubMed
13. S. P. Salcedo, M. I. Marchesini, H. Lelouard, et al., “Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1,” PLoS Pathogens, vol. 4, no. 2, p. e21, 2008. View at Publisher · View at Google Scholar · View at PubMed
14. M. B. Zaitseva, H. Golding, M. Betts, et al., “Human peripheral blood $\text{CD}{4}^{+}$ and $\text{CD}{8}^{+}$ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus,” Infection and Immunity, vol. 63, no. 7, pp. 2720–2728, 1995.
15. C. L. Baldwin and R. Goenka, “Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?,” Critical Reviews in Immunology, vol. 26, no. 5, pp. 407–442, 2006.
16. E. Billard, J. Dornand, and A. Gross, “Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion,” Infection and Immunity, vol. 75, no. 10, pp. 4980–4989, 2007. View at Publisher · View at Google Scholar · View at PubMed
17. G. H. Giambartolomei, M. V. Delpino, M. E. Cahanovich, et al., “Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis,” The Journal of Infectious Diseases, vol. 186, no. 2, pp. 252–259, 2002. View at Publisher · View at Google Scholar · View at PubMed
18. E. Zacharioudaki, P. Boura, I. Kountouras, P. Skendros, and N. Lefkos, “Cytokine regulation and establishment of chronicity in brucellosis,” Immunology Letters, vol. 87, p. 51, 2003, abstract EFIS.
19. A. Rafiei, S. K. Ardestani, A. Kariminia, A. Keyhani, M. Mohraz, and A. Amirkhani, “Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease,” Journal of Infection, vol. 53, no. 5, pp. 315–324, 2006. View at Publisher · View at Google Scholar · View at PubMed
20. S. Kinikli, N. Turkcapar, M. B. Kucukay, G. Keskin, and G. Kinikli, “In vitro nonspecific mitogenic response of T-cell subsets in acute and chronic brucellosis,” Diagnostic Microbiology and Infectious Disease, vol. 52, no. 3, pp. 229–233, 2005. View at Publisher · View at Google Scholar · View at PubMed
21. P. Skendros, P. Boura, D. Chrisagis, and M. Raptopoulou-Gigi, “Diminished percentage of CD4+ T-lymphocytes expressing interleukine-2 receptor alpha in chronic brucellosis,” Journal of Infection, vol. 54, no. 2, pp. 192–197, 2007. View at Publisher · View at Google Scholar · View at PubMed
22. D. J. Lenschow, T. L. Walunas, and J. A. Bluestone, “CD28/B7 system of T cell costimulation,” Annual Review of Immunology, vol. 14, pp. 233–258, 1996. View at Publisher · View at Google Scholar · View at PubMed
23. P. Skendros, P. Boura, F. Kamaria, and M. Raptopoulou-Gigi, “CD80/CD28 co-stimulation in human brucellosis,” Clinical and Experimental Immunology, vol. 146, no. 3, pp. 400–408, 2006. View at Publisher · View at Google Scholar · View at PubMed
24. N. Lapaque, I. Moriyon, E. Moreno, and J.-P. Gorvel, “Brucella lipopolysaccharide acts as a virulence factor,” Current Opinion in Microbiology, vol. 8, no. 1, pp. 60–66, 2005. View at Publisher · View at Google Scholar · View at PubMed
25. P. G. Cardoso, G. C. Macedo, V. Azevedo, and S. C. Oliveira, “Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system,” Microbial Cell Factories, vol. 5, article 13, pp. 1–11, 2006. View at Publisher · View at Google Scholar · View at PubMed
26. E. Billard, J. Dornand, and A. Gross, “Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells,” Infection and Immunity, vol. 75, no. 12, pp. 5916–5923, 2007. View at Publisher · View at Google Scholar · View at PubMed
27. J. Goldstein, T. Hoffman, C. Frasch, et al., “Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines,” Infection and Immunity, vol. 60, no. 4, pp. 1385–1389, 1992.
28. M. Guha and N. Mackman, “LPS induction of gene expression in human monocytes,” Cellular Signalling, vol. 13, no. 2, pp. 85–94, 2001. View at Publisher · View at Google Scholar
29. T. Mattern, A. Thanhäuser, N. Reiling, et al., “Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes,” Journal of Immunology, vol. 153, no. 7, pp. 2996–3004, 1994.
30. A. J. Ulmer, H.-D. Flad, Th. Rietschel, and T. Mattern, “Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS),” Toxicology, vol. 152, no. 1–3, pp. 37–45, 2000. View at Publisher · View at Google Scholar
31. E. J. Chien, C.-C. Chen, C.-H. Chien, T.-P. Yeh, and L.-M. Lu, “Activation and up-regulation of phospholipase D expression by lipopolysaccharide in human peripheral T cells,” Chinese Journal of Physiology, vol. 47, no. 4, pp. 203–209, 2004.
32. A. K. De, C. L. Miller-Graziano, S. E. Calvano, et al., “Selective activation of peripheral blood T cell subsets by endotoxin infusion in healthy human subjects corresponds to differential chemokine activation,” Journal of Immunology, vol. 175, no. 9, pp. 6155–6162, 2005.
33. M. J. Corbel, “Brucellosis: an overview,” Emerging Infectious Diseases, vol. 3, no. 2, pp. 213–221, 1997.
34. M. Zaitseva, H. Golding, J. Manischewitz, D. Webb, and B. Golding, “Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus,” Infection and Immunity, vol. 64, no. 8, pp. 3109–3117, 1996.
35. S. Hodge, G. Hodge, R. Flower, and P. Han, “Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood,” Scandinavian Journal of Immunology, vol. 51, no. 1, pp. 67–72, 2000. View at Publisher · View at Google Scholar
36. A. Hutchings, W. M. Purcell, and M. R. Benfield, “Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression,” Clinical and Experimental Immunology, vol. 118, no. 2, pp. 247–252, 1999. View at Publisher · View at Google Scholar
37. M. Refik, N. Mehmet, R. Durmaz, and Y. Ersoy, “Cytokine profile and nitric oxide levels in sera from patients with brucellosis,” Brazilian Journal of Medical and Biological Research, vol. 37, no. 11, pp. 1659–1663, 2004. View at Publisher · View at Google Scholar
38. A. C. Makis, E. Galanakis, E. C. Hatzimichael, Z. L. Papadopoulou, A. Siamopoulou, and K. L. Bourantas, “Serum levels of soluble interleukin-2 receptor alpha (sIL-2R$\alpha$) as a predictor of outcome in brucellosis,” Journal of Infection, vol. 51, no. 3, pp. 206–210, 2005. View at Publisher · View at Google Scholar · View at PubMed
39. K. Ahmed, K. A. Al-Matrouk, G. Martinez, K. Oishi, V. O. Rotimi, and T. Nagatake, “Increased serum levels of interferon-$\gamma$ and interleukin-12 during human brucellosis,” American Journal of Tropical Medicine and Hygiene, vol. 61, no. 3, pp. 425–427, 1999.
40. K. Demirdag, M. Ozden, A. Kalkan, A. Godekmerdan, and S. S. Kilic, “Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers,” FEMS Immunology and Medical Microbiology, vol. 39, no. 2, pp. 149–153, 2003. View at Publisher · View at Google Scholar
41. T. Muchamuel, S. Menon, P. Pisacane, M. C. Howard, and D. A. Cockayne, “IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-$\alpha$, IFN-$\gamma$, and IL-12 production,” Journal of Immunology, vol. 158, no. 6, pp. 2898–2903, 1997.
42. T. Mattern, H.-D. Flad, L. Brade, E. T. Rietschel, and A. J. Ulmer, “Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions,” Journal of Immunology, vol. 160, no. 7, pp. 3412–3418, 1998.
43. P. Boura, G. Tsapas, J. Kountouras, and E. Zaharioudaki, “Interferon-A 2a administration in chronic anergic brucellosis,” Hepato-Gastroenterology, vol. 42, no. 6, pp. 919–922, 1995.
44. P. Boura, P. Skendros, J. Kountouras, E. Zacharioudaki, and T. Tsapas, “Effect of bacterial extracts on the immunologic profile in chronic relapsing Brucellosis patients,” International Journal of Immunopathology and Pharmacology, vol. 12, no. 2, pp. 103–111, 1999.
45. M. A. Dobrovolskaia and S. N. Vogel, “Toll receptors, CD14, and macrophage activation and deactivation by LPS,” Microbes and Infection, vol. 4, no. 9, pp. 903–914, 2002. View at Publisher · View at Google Scholar
46. W. Heagy, C. Hansen, K. Nieman, J. L. Rodriguez, and M. A. West, “Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes,” The Journal of Trauma-Injury Infection & Critical Care, vol. 49, no. 5, pp. 806–814, 2000. View at Publisher · View at Google Scholar
47. F. N. Lauw, T. ten Hove, P. E. P. Dekkers, E. de Jonge, S. J. H. van Deventer, and T. van der Poll, “Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin,” Infection and Immunity, vol. 68, no. 3, pp. 1014–1018, 2000. View at Publisher · View at Google Scholar
48. T. K. Varma, T. E. Toliver-Kinsky, C. Y. Lin, A. P. Koutrouvelis, J. E. Nichols, and E. R. Sherwood, “Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice,” Infection and Immunity, vol. 69, no. 9, pp. 5249–5263, 2001. View at Publisher · View at Google Scholar
49. H. Reiser and M. J. Stadecker, “Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases,” The New England Journal of Medicine, vol. 335, no. 18, pp. 1369–1377, 1996. View at Publisher · View at Google Scholar
50. N. L. Harris and F. Ronchese, “The role of B7 costimulation in T-cell immunity,” Immunology and Cell Biology, vol. 77, no. 4, pp. 304–311, 1999. View at Publisher · View at Google Scholar
51. G. Martínez de Tejada, J. Pizarro-Cerdá, E. Moreno, and I. Moriyón, “The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides,” Infection and Immunity, vol. 63, no. 8, pp. 3054–3061, 1995.
52. C. M. Fernandez-Prada, E. B. Zelazowska, M. Nikolich, et al., “Interactions between Brucella melitensis and human phagocytes: bacterial surface O-polysaccharide inhibits phagocytosis, bacterial killing, and subsequent host cell apoptosis,” Infection and Immunity, vol. 71, no. 4, pp. 2110–2119, 2003. View at Publisher · View at Google Scholar
53. M. G. Rittig, A. Kaufmann, A. Robins, et al., “Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes,” Journal of Leukocyte Biology, vol. 74, no. 6, pp. 1045–1055, 2003. View at Publisher · View at Google Scholar · View at PubMed
54. C. M. Fernandez-Prada, M. Nikolich, R. Vemulapalli, et al., “Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis,” Infection and Immunity, vol. 69, no. 7, pp. 4407–4416, 2001. View at Publisher · View at Google Scholar · View at PubMed
55. A. Kariminia, G. Kavoossy, S. Khatami, E. Zowghi, and S. K. Ardestani, “Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 25, no. 2, pp. 85–93, 2002. View at Publisher · View at Google Scholar
56. P. Barrionuevo, J. Cassataro, M. V. Delpino, et al., “Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2,” Infection and Immunity, vol. 76, no. 1, pp. 250–262, 2008. View at Publisher · View at Google Scholar · View at PubMed